TrialMultiple sclerosis (Houndmills, Basingstoke, England)2018

Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets.

Nicola De Stefano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.